Harmony Biosciences Holdings Stock Price on September 5, 2023
| HRMY Stock | USD 34.20 0.52 1.50% |
Below is the normalized historical share price chart for Harmony Biosciences Holdings extending back to August 19, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Harmony Biosciences stands at 34.20, as last reported on the 29th of December, with the highest price reaching 34.96 and the lowest price hitting 33.81 during the day.
If you're considering investing in Harmony Stock, it is important to understand the factors that can impact its price. Harmony Biosciences holds Efficiency (Sharpe) Ratio of -0.0442, which attests that the entity had a -0.0442% return per unit of risk over the last 3 months. Harmony Biosciences exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Harmony Biosciences' Standard Deviation of 3.89, market risk adjusted performance of (0.08), and insignificant Risk Adjusted Performance to validate the risk estimate we provide.
At this time, Harmony Biosciences' Total Stockholder Equity is fairly stable compared to the past year. Common Stock Shares Outstanding is likely to rise to about 64.3 M in 2024, whereas Liabilities And Stockholders Equity is likely to drop slightly above 466 M in 2024. . At this time, Harmony Biosciences' Price Earnings Ratio is fairly stable compared to the past year. Price Book Value Ratio is likely to rise to 4.32 in 2024, whereas Price To Sales Ratio is likely to drop 3.14 in 2024. Harmony Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 19th of August 2020 | 200 Day MA 33.1408 | 50 Day MA 34.1773 | Beta 0.77 |
Harmony |
Sharpe Ratio = -0.0442
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | HRMY |
Estimated Market Risk
| 3.84 actual daily | 34 66% of assets are more volatile |
Expected Return
| -0.17 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Harmony Biosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Harmony Biosciences by adding Harmony Biosciences to a well-diversified portfolio.
Price Book 3.3179 | Enterprise Value Ebitda 8.0504 | Price Sales 2.8604 | Shares Float 44.1 M | Wall Street Target Price 53.875 |
Related Headline
Design Therapeutics Headline on 5th of September 2023
Filed transaction by Design Therapeutics Inc director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Harmony Biosciences Valuation on September 5, 2023
It is possible to determine the worth of Harmony Biosciences on a given historical date. On September 5, 2023 Harmony was worth 36.18 at the beginning of the trading date compared to the closed value of 35.22. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Harmony Biosciences stock. Still, in general, we apply an absolute valuation method to find Harmony Biosciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Harmony Biosciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Harmony Biosciences' related companies.
| Open | High | Low | Close | Volume | |
| 36.56 | 36.80 | 35.70 | 36.09 | 534,100 | |
09/05/2023 | 36.18 | 37.00 | 35.09 | 35.22 | 724,900 |
| 35.13 | 36.79 | 35.13 | 36.64 | 789,300 |
| Backtest Harmony Biosciences | | | Harmony Biosciences History | | | Harmony Biosciences Valuation | Previous | Next |
Harmony Biosciences Trading Date Momentum on September 5, 2023
| On September 06 2023 Harmony Biosciences Holdings was traded for 36.64 at the closing time. The top price for the day was 36.79 and the lowest listed price was 35.13 . The trading volume for the day was 789.3 K. The trading history from September 6, 2023 was a factor to the next trading day price jump. The trading delta at closing time against the next closing price was 4.03% . The trading delta at closing time against the current closing price is 7.89% . |
Harmony Biosciences Fundamentals Correlations and Trends
By evaluating Harmony Biosciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Harmony Biosciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Harmony financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Harmony Biosciences Stock history
Harmony Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Harmony is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Harmony Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Harmony Biosciences stock prices may prove useful in developing a viable investing in Harmony Biosciences
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 60.4 M | 64.3 M | |
| Net Income Applicable To Common Shares | 208.7 M | 219.1 M |
Harmony Biosciences Quarterly Net Working Capital |
|
Harmony Biosciences Stock Technical Analysis
Harmony Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Harmony Biosciences Period Price Range
Low | December 29, 2024
| High |
0.00 | 0.00 |
Harmony Biosciences Holdings cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Harmony Biosciences December 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Harmony Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Harmony Biosciences shares will generate the highest return on investment. By undertsting and applying Harmony Biosciences stock market strength indicators, traders can identify Harmony Biosciences Holdings entry and exit signals to maximize returns
Harmony Biosciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Harmony Biosciences' price direction in advance. Along with the technical and fundamental analysis of Harmony Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Harmony to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.08) | |||
| Total Risk Alpha | (0.17) | |||
| Treynor Ratio | (0.09) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Harmony Stock Analysis
When running Harmony Biosciences' price analysis, check to measure Harmony Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harmony Biosciences is operating at the current time. Most of Harmony Biosciences' value examination focuses on studying past and present price action to predict the probability of Harmony Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harmony Biosciences' price. Additionally, you may evaluate how the addition of Harmony Biosciences to your portfolios can decrease your overall portfolio volatility.